Magnetic resonance imaging of the brain in phenylketonuria

No To Hattatsu

Volumn 38, Issue 1, 2006, Pages 27-31

  Izumi, Mina ^a,b   Yamazaki, Hirotaka ^a   Nakabayashi, Hiroki ^a   Owada, Misao ^c  

^a NIHON UNIVERSITY   (Japan)

^b Department of Pediatrics   (Japan)

^c KAGAWA NUTRITION UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CHILD; CLINICAL FEATURE; DIAGNOSTIC IMAGING; FLUID ATTENUATED INVERSION RECOVERY MAGNETIC RESONANCE; HUMAN; HYPERPHENYLALANINEMIA; MASS SCREENING; MENTAL DEFICIENCY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENYLKETONURIA; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BRAIN; CHILD; CHILD, PRESCHOOL; HUMANS; MAGNETIC RESONANCE IMAGING; MENTAL RETARDATION; PHENYLALANINE; PHENYLKETONURIAS;

EID: 30344463290     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Seashore MR, Friedman E, Novelly RA, Bapat V. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction. Pediatrics 1985; 75:226-32.
2. Cabalska B, Duczynska N, Borzymowska J, Zorska K, Koslacz-Folga A, Bozkowa K. Termination of dietary treatment in phenylketonuria. Eur J Pediatr 1977;123:253-62.
3. Scriber CR, Kaufman S. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. Vol. II. New York: McGraw-Hill, 2001:1667-724.
4. Arnold GL, Kramer BM, Kirby RS, et al. Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria. Acta Paediatr 1998;87:565-70.
5. Diamond A. Phenylalanine levels of 6-10 mg/dl may not be as benign as once thought. Acta Paediatr Suppl 1994;407:89-91.
6. Feldmann R, Denecke J, Pietsch M, Grenzebach M, Weglage J. Phenylketonuria: no specific frontal lobe-dependent neuropsychological deficits of early-treated patients in comparison with diabetics. Pediatr Res 2002;51:761-5.
7. Pietz J. Neurological aspects of adult phenylketonuria. Curr Opin Neurol 1998;11:679-88.
8. Bick U, Ullich K, Stober U, et al. White matter abnormalities in patients with treated hyperphenylalaniaemia: magenetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr 1993; 152:1012-20.
9. Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging of the brain in phenylketonuria. Lancet 1994;344:87-90.
10. Pietz J, Meyding-Lamade UK, Schumidt H. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency. Eur J Pediatr 1996;155:569-73.
11. Weglage J, Bick U, Schuierer G, et al. Progression of the cerebral white matter abnormalities in early treated patients with phenylketonuria during adolescence. Neuropediatrics 1997;28: 239-40.
12. Cleary MA, Walter JH, Wraith JE, White F, Tyler K, Jenkins JP. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 1995;127:251-5.
13. Dezortova M, Hajek M, Tintera J, Helcmanoval L, Sykova E. MR in phenylketonuria-related brain lesions. Acta Radial 2001;42: 459-66.
14. Weglage J, Schuierer G, Kurlemann G, Bick R, Ullrich K, et al. Different degrees of white matter abnormalities in untreated phenylketonurics: findings in magnetic resonance imaging. J Inherit Metab Dis 1993;16:1047-8.
15. Ullich K, Weglage J, Schuierer G, et al. Cranial MRI in PKU: evaluation of a critical threshold for blood phenylalanine. Neuropediatrics 1994;25:278-9.